Cited by 950T-cell and B-cell ImmunologyGalectins and Cancer BiologyPsoriasis: Treatment and Pathogenesis

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

CD69: from activation marker to metabolic gatekeeper

Open access

Cibrián, Danay, Sánchez‐Madrid, Francisco·2017·European Journal of Immunology

DOI 10.1002/eji.201646837PMC PMC6485631

Open this paper in CoChat — free account Open PDF

Abstract

CD69 is a membrane‐bound, type II C‐lectin receptor. It is a classical early marker of lymphocyte activation due to its rapid appearance on the surface of the plasma membrane after stimulation. CD69 is expressed by several subsets of tissue resident immune cells, including resident memory T (TRM) cells and gamma delta (γδ) T cells, and is therefore considered a marker of tissue retention. Recent evidence has revealed that CD69 regulates some specific functions of selected T‐cell subsets, determining the migration‐retention ratio as well as the acquisition of effector or regulatory phenotypes. Specifically, CD69 regulates the differentiation of regulatory T (Treg) cells as well as the secretion of IFN‐γ, IL‐17, and IL‐22. The identification of putative CD69 ligands, such as Galectin‐1 (Gal‐1), suggests that CD69‐induced signaling can be regulated not only during cognate contacts between T cells and antigen‐presenting cells in lymphoid organs, but also in the periphery, where cytokines and other metabolites control the final outcome of the immune response. Here, we will discuss new aspects of the molecular signaling mediated by CD69 and its involvement in the metabolic reprogramming regulating TH‐effector lineages.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/eji.201646837

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
Quintana, F. J., Basso, A. S., Iglesias, A. H., Korn, T., Farez, M. F., Bettelli, E., Caccamo, M., Oukka, M., & Weiner, H. L. (2008) · Nature · doi:10.1038/nature06880 · Cited by 1,865
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
Dang, E. V., Barbi, J., Yang, H.-Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z., Fu, J., Kim, Y., Yen, H.-R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.033 · Cited by 1,595
The developmental pathway for CD103+CD8+ tissue-resident memory T cells of skin
Mackay, L. K., Rahimpour, A., Ma, J. Z., Collins, N., Stock, A. T., Hafon, M.-L., Vega-Ramos, J., Lauzurica, P., Mueller, S. N., Stefanovic, T., et al. (2013) · Nature Immunology · doi:10.1038/ni.2744 · Cited by 1,331
CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs
Shiow, L. R., Rosen, D. B., Brdičková, N., Xu, Y., An, J., Lanier, L. L., Cyster, J. G., & Matloubian, M. (2006) · Nature · doi:10.1038/nature04606 · Cited by 1,189
The Glucose Transporter Glut1 Is Selectively Essential for CD4 T Cell Activation and Effector Function
Macintyre, A. N., Gerriets, V. A., Nichols, A., Michalek, R. D., Rudolph, M. C., Deoliveira, D., Anderson, S. M., Abel, E. D., Chen, B. J., Hale, L. P., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.05.004 · Cited by 1,169
Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation
Sinclair, L. V., Rolf, J., Emslie, E., Shi, Y.-B., Taylor, P. M., & Cantrell, D. A. (2013) · Nature Immunology · doi:10.1038/ni.2556 · Cited by 930
Inflammatory T Cell Responses Rely on Amino Acid Transporter ASCT2 Facilitation of Glutamine Uptake and mTORC1 Kinase Activation
Nakaya, M., Xiao, Y., Zhou, X., Chang, J., Chang, M., Cheng, X., Blonska, M., Lin, X., & Sun, S. (2014) · Immunity · doi:10.1016/j.immuni.2014.04.007 · Cited by 902
Glutamine Uptake and Metabolism Are Coordinately Regulated by ERK/MAPK during T Lymphocyte Activation
Carr, E. L., Kelman, A., Wu, G. S., Gopaul, R., Senkevitch, E., Aghvanyan, A., Turay, A. M., & Frauwirth, K. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903586 · Cited by 830
Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells
Skon, C. N., Lee, J.-Y., Anderson, K. G., Masopust, D., Hogquist, K. A., & Jameson, S. C. (2013) · Nature Immunology · doi:10.1038/ni.2745 · Cited by 817
The outs and the ins of sphingosine-1-phosphate in immunity
Spiegel, S., & Milstien, S. (2011) · Nature Reviews Immunology · doi:10.1038/nri2974 · Cited by 810

Flagged first, then by citations

Show all 63 references

Research works printed but not linked: 2

10.1172/JCI200319112 · DOI
Sanchez‐Diaz R., 2017, Thymus‐derived Treg cell development is regulated by C‐type‐lectin‐mediated BIC/miRNA155 expression, Mol. Cell Biol., 31

Sorted by citations

Items 901–950 of 950

Focal therapeutic conditions matter: How energy affects antigen presentation and T cell activation
Jiang, M., Shao, Q., Vallin, J. R., Shimizu, Y., Burbach, B. J., Azarin, S. M., & Bischof, J. C. (2026) · Bioengineering & Translational Medicine · doi:10.1002/btm2.70152
Bioinformatics-based Investigation to Unveiling The miRNA-Immunity Axis in The Tumor Microenvironment of Pancreatic Cancer
Al-Janaby, M. S., Mannoush, S. H., Al-Janabi, S. S., Suleiman, A. A., Abdulkareem, A. H., Alalwani, A. K., & Fahad, M. M. (2026) · F1000Research · doi:10.12688/f1000research.172407.3
Immunomodulatory effects and clinical application of galectins in ocular surface
Bao, X., Mei, Z., Fu, Y., & Chen, W. (2026) · The Ocular Surface · doi:10.1016/j.jtos.2026.06.006
Cell-Cell-Seq resolves contact-associated NK cell activation in defined tumor cell dyadsPreprint
Liang, J., Shao, D., Carlo, D. D., & de Rutte, J. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.04.730259
Origins of CD8 tissue resident memory
Topham, D. J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1834618
Distinct Programs of Tissue Adaptation Shape Vitreous CD4+ and CD8+ T-cell States in Chronic UveitisPreprint
Bhanja, S., Ghosh, S., Negi, J., Raina, A., Alam, K., Forrester, J. V., Kumar, P., & Basu, S. (2026) · bioRxiv · doi:10.64898/2026.06.11.731765
Multiple sclerosis patients under treatment with interferon β1-a or ocrelizumab exhibit different T and B cell responses to SARS-CoV-2 vaccine
Liotti, A., Maniscalco, G. T., Ferrara, A. L., Mazzone, V., Dehbozorgi, M., Szabó, A., Belardo, M., Marcogiuseppe, D., Martino, A., Battista, M. E. D., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1773417
eIF3 interactions with miRNAs involved in translational control of early T cell activationPreprint
Mukherjee, P., Shin, J., Hermosillo, C., Ching, C. Y., Koga, Y., Bianchi, A. H., Silva, D. D., & Cate, J. H. D. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.17.732961
CD69 blockade restores the bone marrow niche and delays leukemogenesis in a mouse model of Nras G12D -driven chronic myelomonocytic leukemia
Li, Y., Jiang, X., Gu, Y., Zha, X., Wu, J., Wu, X., Qi, C., Chen, S., Li, Y., Jin, Z., et al. (2026) · Cancer Biology & Therapy · doi:10.1080/15384047.2026.2692184
Hypoxia preconditioning enhances the cardioprotective effects of induced regulatory T cells after myocardial infarction through HIF-1α-mediated mechanisms
Xia, J., Niu, Z., Zhang, S., Gao, C., Zhang, S., Pang, Y., & Hou, L. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117049
Immunophenotypic Profiling of Lymphocyte Subsets in Children and Adolescents With Acute Lymphoblastic Leukaemia: Immune Dysregulation Before and After Remission
Nafady‐Hego, H., Flemban, A. F., Kabrah, S. M., Elmoneim, H. M. A., Aly, E., Elgendy, M., bukhari, T. A. A., Elgendy, H. M., Alaa, H., Almaghrabi, R. O. M., et al. (2026) · Journal of Immunology Research · doi:10.1155/jimr/5591215
Pathogenic type-2 immunity beyond allergy: the role of Th2 cell heterogeneity in helminth infections
Queiroz, C. P., & Gazzinelli-Guimarães, P. H. (2026) · Infection and Immunity · doi:10.1128/iai.00556-25
PKC inhibitors reveal PKC isoforms involved in HIV latency reversal and immunomodulation
Zaikos, T. D., Pham, V., Chou, T. C., Moran, J. A., Turner, S. R., Yu, B. H., Hourani, R., Ranjan, A., Zack, J. A., Wender, P. A., et al. (2026) · Journal of Virology · doi:10.1128/jvi.00500-26
Detection of SARS-CoV-2 epitope-specific CD8+ T cell responses in convalescent COVID individuals using HLA-A*02 dimers
Lopes-Ribeiro, Á., Santos, T. A. P., Félix, M. E. M., Corrêa-Dias, L. C., Martins‐Filho, O. A., Peruhype-Magalhães, V., Teixeira-Carvalho, A., Tsuji, M., & Coelho-dos-Reis, J. G. A. (2026) · Journal of Immunological Methods · doi:10.1016/j.jim.2026.114089
From sentinels to soldiers: tissue-resident cells for next-generation immunotherapy
Ko, N., Esperante, D., Mendoza-Roldan, F., Revueltas, E. S., Jimenez-Miranda, A., Muñoz-Cruz, S., Bonifaz, L. C., & Gajón, J. A. (2026) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiag102
Immunosuppressive effects of voclosporin in inflammatory bowel disease through targeted inhibition of SLP-76 and metabolic reprogramming
Loges, L., Gabel, M., Knauss, A., Atreya, R. N., Gessner, A., Bartels, N., Neurath, M. F., & Weigmann, B. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag175
Age‐associated immune dysregulation links to disease severity in macrolide‐resistant Mycoplasma pneumoniae pneumonia: Insights from a comparative juvenile–adult mouse model
Li, X., Wang, Y., Liu, L. D., Gong, M., Wang, J., Cao, Y., Sun, Z., Meng, F., Wang, Q., Wu, H., et al. (2026) · Animal Models and Experimental Medicine · doi:10.1002/ame2.70231
Dual bispecific protein engagers targeting mesothelin and NECTIN2 deliver CD3/CD28 signals to activate cytotoxic T cells against colorectal cancer patient-derived organoids
Thongchot, S., Supimon, K., Phanthaphol, N., Kanoksing, P., Mitchasin, T., Chieochansin, T., Riansuwan, W., Prapasrivorakul, S., Ovartchaiyapong, P., Mongkhonsupphawan, A., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-64391-1
A novel CD69 binding ankyrin repeat protein (Ankyron®) enables detection of early activated and antigen-specific T cells in pigs
Bettin, L., Borysova, T., Dangl, T., Odasso, J. B., & Käser, T. (2026) · Scientific Reports · doi:10.1038/s41598-026-64514-8
DeSpaST: deconvoluting spatial transcriptomics signals to cell-level resolution using histology images
Zhou, Q., Wang, S., Jiang, Y., Liu, Y., Wanyan, T., Chen, K., Wen, Z., Chi, Z., Quan, P., Lutz, K. C., et al. (2026) · Briefings in Bioinformatics · doi:10.1093/bib/bbag415
The Y105 phosphosite between the SH3.1 and SH3.2 domains of Nck1 regulates its binding to CD3ϵ
Ngoenkam, J., Wipa, P., Paensuwan, P., Chanaphai, W., Nuiyen, A., Suriyaphol, P., Schamel, W. W. A., & Pongcharoen, S. (2026) · iScience · doi:10.1016/j.isci.2026.117119
Spatial and functional specialization of human splenic innate lymphoid cells
Colpitts, S. J., Jegatheeswaran, S., Mashhouri, S., Hagerman, A., El-Maklizi, M., Murshed, H., Mak, M. L., Reid, K. T., Murphy, J. M., Mathews, J. A., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-76100-7
Absence of EGFR signalling in granulocytic cells relieves immunosuppression sensitising CRC metastases to immune checkpoint therapy
Moreno‐Viedma, V., Adachi-Fernandez, E., Krauß, D., Mohr, T. T., Blauensteiner, B., Buresch, J., Mireva, L., Kokkinogenis, E., Filipits, M., Holcmann, M., et al. (2026) · Cell Death and Differentiation · doi:10.1038/s41418-026-01828-0
CCR5/CCR6 Chemokine Receptor Profiles Differ in γδTCR Intensity-Defined Subsets but Remain Conserved Across Conventional and NK-like γδT Cells During Healthy First-Trimester Pregnancy
Alrawashdeh, B., Jáksó, P., Forró, B., Várnagy, Á., & Barakonyi, A. (2026) · Biology · doi:10.3390/biology15161386
CRHR2 activation by urocortins regulates splenic microbiota-immune-brain axis in a single prolonged stress model of post-traumatic stress in male rats
Dziewiczová, L., Tillinger, A., Horváthová, Ľ., Štefančíková, S., Osacká, J., & Vargovič, P. (2026) · Neuropeptides · doi:10.1016/j.npep.2026.102651
Dual Role of Tamoxifen in Enhancing STING and CEACAM1 Expression to Prime a Favorable Tumor Microenvironment for Anti‐TIM3 Immunotherapy
Aberin, M. A. E., Singh, S., Chatterjee, S., Sui, G., Wang, Y.-F., Lu, Y.-T., Lee, Y.-L., Lin, K.-Y., Khag, J., Liu, T.-Y., et al. (2026) · Advanced Science · doi:10.1002/advs.202503303
Zooming in on T-cell protection
Hanke, T. (2026) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000001062
T-cell activation profiles predict outcomes of neoadjuvant therapy in breast cancer
Cai, C., Huang, J., Li, J., 郑赛香, Lin, D., Duan, C., & Xu, Y. (2026) · Clinical Immunology · doi:10.1016/j.clim.2026.110762
TNF and CD107a-dominated enhanced effector responses of CD8+ MAIT cells to Escherichia coli stimulation in patients with aplastic anemia
Qin, Q., Zhang, Y., Wu, S., Fan, S., He, X., Li, X., Bian, W., Li, Y., & Li, B. (2026) · Cellular Immunology · doi:10.1016/j.cellimm.2026.105152
Identification of a Novel Small Molecule Facilitating HIV Elimination by the “Shock‐And‐Kill” Approach
Hara, Y., Kitamura, H., Matsuda, K., Fujisaki, C., Sukegawa, S., Tanimoto, K., Maeda, K., & Takeuchi, H. (2026) · Journal of Medical Virology · doi:10.1002/jmv.71131
Engineering a Virus-like Nanovaccine for Durable and Potent Antigen-Specific Adoptive Immunity
Liu, N., Liu, Y., Hou, Z., Miao, Y., Chen, L., Xiao, Z., Shen, J., Zhang, Q., Yang, Y., Fei, X., et al. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c11094
Comprehensive immune profiling of human peripheral blood mononuclear cells using two complementary spectral flow cytometry panels encompassing 60 unique markers
Rietdijk, M. H., Kuhnen, L. C., van den Braber, M., Paul, A., Pascutti, M. F., & García-Vallejo, J. J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1894779
scGSI: Graph-guided self-supervised integration of paired single-cell multi-omics
Chen, X., Yang, Z., Liu, X., Xie, Z., & Guo, W. (2026) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1014773
CD93 at the vascular–immune nexus
Guo, Y., Chen, L., & Zhu, Y. (2026) · Vita · doi:10.15302/vita.2026.08.0068
Sustained microparticle-mediated intracellular immunomodulation enhances tolerogenic dendritic cell stability and antigen-specific Treg induction
Jia, S., Weiser, Z., Rajasekaran, M., DiMitri, L. G., & Deak, P. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1897468
Influence of TRPV1 and TRPV4 cation channel agonists on the expression of activation markers by peripheral blood mononuclear cells
Naumov, D. E., Sugaylo, I. Y., Nekrasova, O. O., Анатольевна, Г. Д., & Maltseva, T. A. (2026) · Bulletin physiology and pathology of respiration · doi:10.36604/1998-5029-2026-101-84-93
Deconvolution of the mechanisms of T cell drug response in multiple myeloma induction therapyPreprint
Graybuck, L. T., Okada, L. Y., Chang, W.-L., Garber, J., Sakai, C., Weiss, M. D. A., Zaim, S. R., Hernandez, V., He, Z., Krishnan, U., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.15.751861
Immune remodeling after thymectomy in patients with anti-AChR antibodies
Koizumi, N., Kinoshita, M., Yasumizu, Y., Yata, T., Motooka, D., Yamamura, R., Sano, I., Suzuki, Y., Tanaka, A., Kanakura, M., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1920763
Silver(I) Complexes with Thiosalicylic Acid Derivatives as Promising Antimicrobial, Antibiofilm, and Immunomodulatory Agents
Marinkovic, J., Jurišević, M., Gajović, N., Jovanović, I., Marinković, J. Z., Grujović, M. Ž., Markovic, K., Radojević, I. D., Mijajlović, M. Ž., Nikolić, M. V., et al. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18101213
Albendazole-loaded γ-cyclodextrin metal-organic frameworks sensitize hepatocellular carcinoma to low-dose doxorubicin via ROS-associated immunogenic cell death
Jiang, N., Yin, F., Dang, Q., Chen, G., Wu, X., Wang, S., Wang, X., & Sun, L. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117510
Immunoregulatory artificial lymph nodes restore antigen-specific tolerance in advanced multiple sclerosis
Ji, J., Wang, X., Liu, L., Zhang, J., Wan, J., Li, G., Xie, G., Qi, J., Xuan, L., Yao, Y., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.aea7960
Inhibitory Nectin-2/TIGIT interactions between CD163 + macrophages and CD8 + T cells in spatially defined immune niches associate with poor outcomes in neuroblastomaPreprint
Borst, A. L., Bergsma, F. J., van den Ham, F., Verdonschot, M. E. L., Amini, M., Boltjes, A., van Dam, S., Verberne, N. H., Bonine, N., Leusen, J. H. W., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.07.756693
JAK-inhibitor treatment induces rapid yet incomplete immune reconstitution in STAT1 gain-of-function
Iglesias-Herrero, C., Roosens, W., Galicia, G., Cremer, J., Marques, P. E., Devos, T., Moens, L., Meyts, I., Gijsbers, R., & Schrijvers, R. (2026) · Journal of Human Immunity · doi:10.70962/jhi.20260009
Expression patterns of CD24 and CD27 resolve the origins and gradual differentiation of CD11c+ atypical memory B-cells after malaria infection
Courey‐Ghaouzi, A., Kleberg, L., Mousavian, Z., Lautenbach, M. J., Pirronello, M., Phad, G. E., Forsell, M. N. E., Färnert, A., & Sundling, C. (2026) · The EMBO Journal · doi:10.1038/s44318-026-00941-7
An ER Retrieval-and-Release System Reveals Ligand-Independent Basal Signaling by Cell Surface TCRsPreprint
Juraske, C., Beyer, S., Hartmann, S., Peschkov, D., Ribeiro, E. M., Ebrahimiyan, H., Ruoff, K., Schmid, F. R., Morath, A., Dorer, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.13.758962
Advancing CD38 from a marker of disease activity to an active regulator of interferon responses in juvenile dermatomyositisPreprint
Moser, B., Madubata, C. J., Chou, M. Y., Lotstein, M. L., Zheng, Z., Agashe, T., Almonte-Loya, A., LaFlam, T. N., Rynda, A., Fox, J. P., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.14.758964
A human self-stimulatory CD4+ T cell antigen-presenting cell subset presents and recognizes agonistic self-antigens to sustain exponential autologous clonal expansion
Smallwood, C. K., Sneed, S. L., Williford, C. L., Roof, T. S., & Mannie, M. D. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag274
Beta-2 adrenergic receptor in CD8+ T cells inhibits GVHD through transcriptional modulation of differentiation and exhaustion.
Basu, S., Massalee, R., Mustapha, H., Alzubi, M. A., Choi, C.-Y., Fan, X.-X., & Cao, X.-F. (2026) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2026.10.029
Early peripheral T-cell immune dynamics during anti-PD-1 therapy as potential biomarkers of treatment response in metastatic non-small cell lung cancer: a prospective pilot study
Garev, A., Gesheva, N., Naumova, E., Mishovska, K., Garev, N., & Mihaylova, Z. (2026) · Folia Medica · doi:10.3897/folmed.68.e188485
Time‐Encoded Ligand Presentation via a Magnetically Actuated Hydrogel Mitigates T Cell Exhaustion
Wang, X., Wang, R., Xiang, G., Zhang, X., Wang, L., Wong, W. K., Deng, Y., Yang, Y., Oh, J., Xie, X., et al. (2026) · Advanced Materials · doi:10.1002/adma.75515

Authors: Cibrián, D., & Sánchez‐Madrid, F.
Affiliations: Instituto de Salud Carlos III (ES)
Corresponding author: Sánchez‐Madrid, Francisco
ORCID: Cibrián, Danay
Sánchez‐Madrid, Francisco
Venue: European Journal of Immunology
Publisher: Wiley
Published: 2017-06
Volume: 47
Issue: 6
Pages: 946-953
ISSN: 0014-2980 (ISSN-L)
1521-4141
DOI: 10.1002/eji.201646837
PMC: PMC6485631
OpenAlex: W2610932550
Cited by: 948
References: 63
Citations by year: 2026: 109 · 2025: 175 · 2024: 150 · 2023: 132 · 2022: 134 · 2021: 101 · 2020: 77 · 2019: 44 · 2018: 22 · 2017: 4
FWCI: 4.16
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 7 d)
Locations: European Journal of Immunology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
Funders: Instituto de Salud Carlos III
Federación Española de Enfermedades Raras
European Research Council (ERC‐2011‐AdG294340‐GENTRIS)
Topics: Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Life Sciences › Immunology and Microbiology › Immunology › Galectins and Cancer Biology
Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords: CD69, lymphocyte activation, tissue-resident memory T cells, γδ T cells, Treg differentiation, galectin-1, T cell metabolism, metabolic reprogramming, cytokine production, T cell signaling
MeSH terms: CD69 Antigens, Animals, Antigen-Presenting Cells, Antigens, Differentiation, T-Lymphocyte, Cell Differentiation, Gene Expression Regulation, Humans, Lymphocyte Activation, Signal Transduction, Antigens, CD, T-Lymphocyte Subsets, Cytokines, Interleukin-17, Galectins, Lectins, C-Type, T-Lymphocytes, Regulatory

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

CD69: from activation marker to metabolic gatekeeper

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks